Literature DB >> 35277724

[Benefits of cardiac magnetic resonance diagnostics in patients with heart rhythm disorders : From risk stratification to interventional procedures].

S Oebel1, C Jahnke2, G Hindricks2, I Paetsch2.   

Abstract

Cardiac magnetic resonance imaging (cMRI) now rates among the established diagnostic procedures for the clarification of cardiac disease patterns. In modern clinical electrophysiology, apart from providing basic cardiac diagnostics of patients prior to interventional procedures, the imaging method enables the three-dimensional reconstruction of cardiac target structures of the planned ablation procedure, which can significantly improve the safety and efficacy of the intervention. Furthermore, cMRI has a high significance with respect to risk stratification during implantable cardioverter defibrillator (ICD) evaluation. In addition to an exact determination of ventricular function, its capability for detailed tissue characterization enables the visualization and quantification of fibrotic lesions and scar tissue as potential arrhythmogenic triggers. This anatomic assignment also enables an increased accuracy of the ablation of substrate-based arrhythmia. In comparison to this the interventional cMRI as a direct interface between cMRI and invasive electrophysiology represents a comparably new field of application. Initial clinical experiences in the field of ablation of typical atrial fibrillation could not only confirm the feasibility of the concept but also enabled recognition of the clear advantages of an imaging-guided electrophysiological procedure.
© 2022. The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Ablation; Atrial flutter; Implantable cardioverter defibrillators; Magnetic resonance imaging; Substrate

Mesh:

Year:  2022        PMID: 35277724     DOI: 10.1007/s00059-022-05105-x

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  45 in total

1.  Initial experience in the use of integrated electroanatomic mapping with three-dimensional MR/CT images to guide catheter ablation of atrial fibrillation.

Authors:  Jun Dong; Timm Dickfeld; Darshan Dalal; Aamir Cheema; Chandrasekhar R Vasamreddy; Charles A Henrikson; Joseph E Marine; Henry R Halperin; Ronald D Berger; Joao A C Lima; David A Bluemke; Hugh Calkins
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

2.  Acquired Pulmonary Vein Stenosis After Radiofrequency Ablation for Atrial Fibrillation: Single-Center Experience in Catheter Interventional Treatment.

Authors:  Katharina Schoene; Arash Arya; Cosima Jahnke; Ingo Paetsch; Sotirios Nedios; Sebastian Hilbert; Andreas Bollmann; Gerhard Hindricks; Philipp Sommer
Journal:  JACC Cardiovasc Interv       Date:  2018-08-27       Impact factor: 11.195

3.  Three-dimensional anatomy of the left atrium by magnetic resonance angiography: implications for catheter ablation for atrial fibrillation.

Authors:  Moussa Mansour; Marwan Refaat; Edwin Kevin Heist; Theofanie Mela; Ricardo Cury; Godtfred Holmvang; Jeremy N Ruskin
Journal:  J Cardiovasc Electrophysiol       Date:  2006-07

4.  Combined single-session cardiovascular magnetic resonance: stress perfusion and three-dimensional pulmonary vein angiography for stratification of atrial fibrillation patients with chest pain syndromes prior to catheter ablation.

Authors:  Sabrina Oebel; Ingo Paetsch; Clara Stegmann; Simon Kircher; Philipp Sommer; Arash Arya; Frank Lindemann; Andreas Bollmann; Gerhard Hindricks; Cosima Jahnke
Journal:  Europace       Date:  2019-12-01       Impact factor: 5.214

5.  Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins.

Authors:  M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty
Journal:  N Engl J Med       Date:  1998-09-03       Impact factor: 91.245

6.  Decreased pulmonary perfusion in pulmonary vein stenosis after radiofrequency ablation: assessment with dynamic magnetic resonance perfusion imaging.

Authors:  Alexander Kluge; Thorsten Dill; Okan Ekinci; Jochen Hansel; Christian Hamm; Heinz F Pitschner; Georg Bachmann
Journal:  Chest       Date:  2004-08       Impact factor: 9.410

7.  Assessments of pulmonary vein and left atrial anatomical variants in atrial fibrillation patients for catheter ablation with cardiac CT.

Authors:  Jing Chen; Zhi-Gang Yang; Hua-Yan Xu; Ke Shi; Qi-Hua Long; Ying-Kun Guo
Journal:  Eur Radiol       Date:  2016-05-26       Impact factor: 5.315

Review 8.  The incidence, diagnosis, and management of pulmonary vein stenosis as a complication of atrial fibrillation ablation.

Authors:  Armand Rostamian; Sanjiv M Narayan; Louise Thomson; Michael Fishbein; Robert J Siegel
Journal:  J Interv Card Electrophysiol       Date:  2014-03-14       Impact factor: 1.900

9.  Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation.

Authors:  Robert S Oakes; Troy J Badger; Eugene G Kholmovski; Nazem Akoum; Nathan S Burgon; Eric N Fish; Joshua J E Blauer; Swati N Rao; Edward V R DiBella; Nathan M Segerson; Marcos Daccarett; Jessiciah Windfelder; Christopher J McGann; Dennis Parker; Rob S MacLeod; Nassir F Marrouche
Journal:  Circulation       Date:  2009-03-23       Impact factor: 29.690

10.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.

Authors:  Gerhard Hindricks; Tatjana Potpara; Nikolaos Dagres; Elena Arbelo; Jeroen J Bax; Carina Blomström-Lundqvist; Giuseppe Boriani; Manuel Castella; Gheorghe-Andrei Dan; Polychronis E Dilaveris; Laurent Fauchier; Gerasimos Filippatos; Jonathan M Kalman; Mark La Meir; Deirdre A Lane; Jean-Pierre Lebeau; Maddalena Lettino; Gregory Y H Lip; Fausto J Pinto; G Neil Thomas; Marco Valgimigli; Isabelle C Van Gelder; Bart P Van Putte; Caroline L Watkins
Journal:  Eur Heart J       Date:  2021-02-01       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.